Hanne Vissing Leth

Hanne Vissing Leth currently serves as the Acting CFO at ResoTher Pharma since January 2024 and holds the position of Interim CFO and Chairman of the Audit Committee at Brain+ since June 2021. Previously, Hanne was the Chief Financial Officer and Financial Consultant at Nanovi A/S until June 2024 and contributed as a board member and vice chairman at DIRF from April 2013 to April 2019. Hanne's experience extends to senior roles in investor relations at Zealand Pharma A/S and NeuroSearch A/S, as well as director positions at TopoTarget A/S. Hanne's background includes a strong foundation in finance, with advanced degrees from Aarhus University and HEC Montréal, alongside a diploma from CBS Bestyrelsesuddannelserne.